Journal of Applied Physiology, Vol 77, Issue 3 1325-1332, Copyright © 1994 by American Physiological Society

ARTICLES

Effects of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects in vivo

D. Cheung, H. van der Veen, J. den Hartigh, J. H. Dijkman and P. J. Sterk
Department of Pulmonology, University Hospital Leiden, The Netherlands.

We tested the hypothesis that the inhaled tachykinin substance P (SP) can induce hyperresponsiveness to methacholine in asthmatic subjects in vivo. Nine atopic nonsmoking asthmatic males with normal forced expiratory volume in 1 s (FEV1; > 80% predicted) and increased methacholine sensitivity [provocative concn causing 20% fall in FEV1 (PC20) < 8 mg/ml] participated in a two-period placebo-controlled crossover study. Dose-response curves to SP (0.25-8 mg/ml) and placebo were recorded on 2 randomized days at least 1 wk apart, and methacholine tests were done 24 h before and 2 and 24 h after these challenges. The responses were measured by FEV1 (%fall from baseline). The position of the methacholine dose-response curves was expressed by the PC20 FEV1 and by the maximal response by the plateau level (MFEV1). SP caused a dose-dependent fall in FEV1 (P < 0.001). There was a slight increase in the PC20 FEV1 at 2 and 24 h, which was not significantly different between placebo and SP. Similarly, there was a reduction in MFEV1 at 2 h after both pretreatments. However, at 24 h after SP inhalation, MFEV1 increased compared with placebo. These changes in MFEV1 were significantly different between SP and placebo by 5.2 +/- 2.2% fall (SE) (P < 0.05). We conclude that 1) a bronchoconstrictive dose of SP, compared with placebo, enhances maximal airway narrowing to methacholine in asthma 24 h after inhalation and 2) tolerance develops to high doses of inhaled methacholine. These findings are suggestive of a role of SP in causing excessive airway narrowing in asthma by inflammatory mechanisms.

This article has been cited by other articles:

				J. D. Boot, S. de Haas, S. Tarasevych, C. Roy, L. Wang, D. Amin, J. Cohen, P. J. Sterk, B. Miller, A. Paccaly, et al. Effect of an NK1/NK2 Receptor Antagonist on Airway Responses and Inflammation to Allergen in Asthma Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 450 - 457. [Abstract] [Full Text] [PDF]

				J. Q. Liu, D. Yang, and R. J. Folz A novel bronchial ring bioassay for the evaluation of small airway smooth muscle function in mice Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L281 - L288. [Abstract] [Full Text] [PDF]

				Z.-X. Wu and R. D. Dey Nerve growth factor-enhanced airway responsiveness involves substance P in ferret intrinsic airway neurons Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L111 - L118. [Abstract] [Full Text] [PDF]

				R. A. Joachim, V. Sagach, D. Quarcoo, Q. T. Dinh, P. C. Arck, and B. F. Klapp Neurokinin-1 Receptor Mediates Stress-Exacerbated Allergic Airway Inflammation and Airway Hyperresponsiveness in Mice Psychosom Med, July 1, 2004; 66(4): 564 - 571. [Abstract] [Full Text] [PDF]

				Z.-X. Wu, B. E. Satterfield, and R. D. Dey Substance P released from intrinsic airway neurons contributes to ozone-enhanced airway hyperresponsiveness in ferret trachea J Appl Physiol, August 1, 2003; 95(2): 742 - 750. [Abstract] [Full Text] [PDF]

				K. Maghni, M.-C. Michoud, M. Alles, A. Rubin, V. Govindaraju, C. Meloche, and J. G. Martin Airway Smooth Muscle Cells Express Functional Neurokinin-1 Receptors and the Nerve-Derived Preprotachykinin-A Gene: Regulation by Passive Sensitization Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 103 - 110. [Abstract] [Full Text] [PDF]

				G. Path, A. Braun, N. Meents, S. Kerzel, D. Quarcoo, U. Raap, G. W. Hoyle, W. A. Nockher, and H. Renz Augmentation of Allergic Early-Phase Reaction by Nerve Growth Factor Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 818 - 826. [Abstract] [Full Text]

				J. Van Schoor, G.F. Joos, and R.A. Pauwels Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma Eur. Respir. J., June 1, 2002; 19(6): 997 - 1002. [Abstract] [Full Text] [PDF]

				E. L. J. Van Rensen, P. S. Hiemstra, K. F. Rabe, and P. J. Sterk Assessment of Microvascular Leakage via Sputum Induction: The Role of Substance P and Neurokinin A in Patients with Asthma Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1275 - 1279. [Abstract] [Full Text] [PDF]

				W. L. Rumsey, D. Aharony, R. A. Bialecki, B. M. Abbott, H. G. Barthlow, R. Caccese, S. Ghanekar, D. Lengel, M. McCarthy, B. Wenrich, et al. Pharmacological Characterization of ZD6021: A Novel, Orally Active Antagonist of the Tachykinin Receptors J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 307 - 315. [Abstract] [Full Text]

				C. M. Evans, K. E. Belmonte, R. W. Costello, D. B. Jacoby, G. J. Gleich, and A. D. Fryer Substance P-induced airway hyperreactivity is mediated by neuronal M2 receptor dysfunction Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L477 - L486. [Abstract] [Full Text] [PDF]

				M. SCHUILING, A. B. ZUIDHOF, J. ZAAGSMA, and H. MEURS Involvement of Tachykinin NK1 Receptor in the Development of Allergen-induced Airway Hyperreactivity and Airway Inflammation in Conscious, Unrestrained Guinea Pigs Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 423 - 430. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				J. L. Szarek, B. Spurlock, C. A. Gruetter, and S. Lemke Substance P and capsaicin release prostaglandin E2 from rat intrapulmonary bronchi Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L1006 - L1012. [Abstract] [Full Text] [PDF]

				A. D. KRANEVELD, F. P. NIJKAMP, and A. J. M. VAN OOSTERHOUT Role for Neurokinin-2 Receptor in Interleukin-5-induced Airway Hyperresponsiveness but not Eosinophilia in Guinea Pigs Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 367 - 374. [Abstract] [Full Text]